CHAPEL HILL, N.C., March
9, 2015 /PRNewswire/ -- CROS NT today announced that it
is extending its partnership with DATATRAK as part of
its life science technology portfolio. The partnership allows CROS
NT to provide DATATRAK's Unified eClinical®
platform which includes Electronic Data Capture (EDC), Clinical
Trial Management System (CTMS), randomization and clinical trial
supply management (RTSM) as well as a web-based patient diary
(ePRO).
CROS NT joined DATATRAK CONNECT® Partner program in order
to offer a unified, cloud-based technology solution to enhance the
quality of clinical data in an efficient and convenient manner for
both drug and device development companies. Since joining the
program, CROS NT has implemented DATATRAK's eClinical
platform in a large number of studies across U.S. and Europe.
At the beginning of the year, DATATRAK announced a
new release of its DATATRAK ONE® unified platform with three
applications now available to support individual or cross-study
functionality:
- The Cross Study
Manager enables real time data, analytics and reporting at
the trial or cross-study level for over 100 fields
- The Scheduler
delivers information to the appropriate person in an individual
trial or across a program of studies
- File
Versioning improves data quality with a unified view of
files online in real-time
Paul Fardy, Chief Operations
Officer for CROS NT, said, "Our decision to extend our
participation in the DATATRAK Partner Program is a
reflection of the success we've had in the past implementing the
unified platform in some of our global studies as well as
DATATRAK's commitment to constantly improving the
system's functionality to meet the increasing demands of Sponsors
for real-time data analysis and reporting capabilities."
Laurence P. Birch, Chairman and
CEO for DATATRAK, said. "We are proud to partner with
CROS NT to bring the benefits of our unified platform to trials
around the globe. Our mutual success is driven by delivering
a simplified eClinical platform that removes time consuming and
costly complexity, including data integration and long wait times
for cross-study reporting. We look forward to expanding our
partnership with CROS NT in 2015 and beyond."
Join DATATRAK Thought Leaders:
- Twitter
- LinkedIn
- SlideShare
- The DATATRAK Blog
Tweet: Global CRO @CROSNT extends partnership with
@DATATRAKinc recognizing commitment to removing #clinicaltrial
complexity http://bit.ly/1Mglxvu
About CROS NT
CROS NT is an international Contract Research Organization (CRO)
specialized in clinical data services including Biostatistics
methodology, programming and analysis, Clinical Data Management,
Medical Writing and Clinical Technologies (EDC, ePRO, IWRS, CTMS).
Founded in 1992, CROS NT is well-established in delivering quality,
timely and cost-effective services for pharmaceutical,
biotechnology and medical device companies as well as academic
institutions, associations and other CROs. The company has provided
expert services for over 1,000 pre- and post-market studies in a
very wide range of therapeutic areas and indications.
About DATATRAK International,
Inc.
DATATRAK International is a worldwide technology
and services company delivering Unified
eClinical® solutions and related services for the
clinical trials industry. DATATRAK built its
multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via
DATATRAK's Clinical and Consulting Services group. The
Company delivers a complete portfolio of software products designed
to accelerate the reporting of clinical research data from sites to
sponsors and ultimately regulatory authorities, faster and more
efficiently than loosely integrated technologies. The
DATATRAK ONE® software solution, deployed
worldwide through an ASP or Enterprise Transfer offering, supports
Preclinical and Phase I - Phase IV drug and device studies as well
as device studies in multiple languages throughout the world.
DATATRAK is located in Cleveland,
Ohio; Bryan, Texas; Cary
(RTP), North Carolina,
Chicago, Illinois; and
London, England. For more
information, visit http://www.datatrak.com.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements are made based on
management's expectations, assumptions, estimates and current
beliefs concerning the operations, future results and prospects of
the Company and are subject to uncertainties and factors which are
difficult to predict and, in many instances, are beyond the control
of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking
statements. For a list of certain factors that may cause actual
results to differ materially from those contemplated in these
forward looking statements, please see the Company's report filed
with the OTCQX Market on November 13,
2014 announcing its results for the third quarter 2014. The
Company undertakes no obligation to update publicly or revise any
forward-looking statement whether as a result of new information,
future events or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cros-nt-extends-datatrak-connect-partnership-300047115.html
SOURCE DATATRAK International, Inc.
